Scienjoy Holding Corporation SJ
0.69
(0.02)
(2.82%)
as of 25 Sep
- Market cap
- $29.3M
- P/E
- 3.5×
Follow SJ
| Mar '26 | Sep '25 | Jun '25 | Mar '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
6.30 | — | 4.26 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.29 | — | 0.18 | 0.21 | |
P/FCF ratio |
2.84 | — | 1.81 | 1.97 | |
P/Operating CF |
7.43 | — | 4.73 | 805.30 | |
P/B ratio |
0.61 | — | 0.20 | 0.24 | |
Price to Tangible BV |
10.72 | — | 0.39 | 0.48 | |
EV/Sales |
0.03 | — | (0.04) | 0.00 | |
EV/EBITDA |
0.60 | — | 0.00 | 0.00 | |
EV/Operating CF |
0.34 | — | (0.37) | (0.04) | |
EV/FCF |
0.34 | — | (0.38) | (0.04) | |
Quick Ratio |
3.25 | 4.33 | 3.29 | 3.09 | |
Current Ratio |
3.45 | 4.64 | 3.48 | 3.27 | |
Net Debt/EBITDA |
(29.47) | 0.00 | (13.11) | (21.85) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.20 | 0.00 | 0.95 | 0.97 | |
Operating CF/Net income |
0.00 | — | 2.26 | 0.00 | |
Capex/Depreciation |
— | — | (0.03) | — | |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.95% | — | 5.00% | 6.37% | |
Selling, General and Administrative Expense of Revenue |
6.79% | — | 6.40% | 8.29% | |
Intangible Assets out of Total Assets |
0.00 | 0.42 | 0.41 | 0.42 | |
Share Based Compensation of Revenue |
0.00% | — | 1.69% | 0.00% | |
Graham Net Nets |
0.75 | — | 1.36 | 1.08 | |
Graham Number |
3.05 | — | 4.15 | 0.00 | |
Earnings Yield |
15.87% | — | 23.46% | (30.11%) | |
Free Cash Flow Yield |
35.24% | — | 55.31% | 50.75% | |
Revenue per Share |
0.98 | — | 1.17 | 1.02 | |
Operating CF per Share |
0.00 | — | 0.17 | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | 0.17 | 0.00 | |
Cash per Share |
1.15 | 0.00 | 1.02 | 0.99 | |
Shareholders Equity per Share |
2.07 | 0.00 | 4.03 | 3.90 | |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | |
Book value per Share |
2.07 | 0.00 | 4.03 | 3.90 | |
Free Cash Flow |
— | — | 7.08 | — | |
Working Capital |
41.07 | 52.84 | 55.38 | 51.55 | |
Capital Expenditures |
— | — | (0.04) | — | |
Net Current Asset Value |
39.68 | 43.10 | 45.66 | 41.79 | |
EV/EBIT |
0.60 | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
3.14% | — | 6.47% | (2.96%) | |
Price to Operating Income |
4.94 | — | 3.21 | 4.37 | |
| Other line items | |||||
Average Receivables |
20.52 | 30.09 | 30.12 | 29.81 | |
Average Payables |
3.79 | 3.76 | 5.17 | 5.85 | |
Average Assets |
152.61 | 193.70 | 195.77 | 192.99 | |
Average Common Equity |
128.43 | 166.79 | 163.84 | 158.84 |
Columns are period end dates